$111 Million Equity Investment Round
At ApiJect, we work with pharmaceutical companies to improve how they can fill-finish injectable medicines. Together, we create scalable, cost-efficient drug delivery systems, and assist companies in manufacturing those devices at their facilities or a trusted contract manufacturer.
The ApiJect Platform brings together Blow-Fill-Seal (BFS) aseptic drug packaging with connectable components to create high-quality, prefilled drug delivery systems that can be made at development and commercial scale once approved by appropriate regulators.
We license our technology to help pharma companies and CDMOs around the world efficiently fill-finish their injection drug products in our delivery systems. Our services include drug-specific BFS mold and device design licensing, device design and development, prototype development, and BFS production support.
ApiJect engineers have made advances with BFS by developing proprietary temperature management methods that can potentially enable BFS fill-finish of many temperature-sensitive biologics and vaccines that are not possible on standard BFS lines. Our experts employ a variety of techniques to consistently manage the drug product’s temperature throughout the fill-finish process.